RHYTHM Biosciences Ltd

Research RHYTHM Biosciences Ltd (RHY) on Bullrun: market cap AUD 31.14M. Explore financials, valuation history, model signals, and stock context.

Key Metrics

TickerRHY
ExchangeAU
CountryAustralia
SectorHealthcare
IndustryDiagnostics & Research
CurrencyAUD
Market capAUD 31.14M
Financial periodFY2025

Valuation Snapshot

latest market cap is AUD 31.14M.

Five-year financial history

Year	Revenue	Net income	Free cash flow	Gross margin	Diluted EPS	Cash	Total debt	Equity
FY2025	n/a	n/a	n/a	n/a	-0.01	n/a	n/a	n/a
FY2024	n/a	-AUD 6.86M	-AUD 6.22M	n/a	-0.03	AUD 709.50K	AUD 163.82K	AUD 867.17K
FY2023	n/a	-AUD 8.22M	-AUD 7.06M	n/a	-0.04	AUD 4.12M	AUD 84.61K	AUD 5.87M
FY2022	n/a	-AUD 8.79M	-AUD 6.52M	n/a	-0.04	AUD 7.55M	AUD 170.14K	AUD 7.37M
FY2021	n/a	-AUD 6.61M	-AUD 5.47M	n/a	n/a	AUD 2.23M	n/a	AUD 1.71M

Valuation history

Year	Snapshot date	Market cap	P/E	Dividend yield	Annual dividend/share
2026	2026-08-24	AUD 31.14M	n/a	n/a	0

Dividend history

Latest trailing dividend snapshot: annual dividend/share 0 AUD.

About RHYTHM Biosciences Ltd

Rhythm Biosciences Limited, a medical diagnostics company, provides blood tests for the detection of cancers in Australia and the United States. It offers ColoSTAT, a blood test for the early detection of colorectal cancer; and geneType, a personalized predictive test for predicting risk of chronic disease development. The company was incorporated in 2017 and is headquartered in Parkville, Australia.

Related stock research

Australia stocks Australia Healthcare stocks A-Z stock index

Other Healthcare stocks

Microba Life Sciences Limited (F3Y) Inoviq Ltd (IIQ) Imexhs Ltd (IME) Monash Ivf Group Ltd (MVF) Sonic Healthcare Limited (SAB) Adalta Ltd (1AD) 4DMEDICAL Ltd (4DX) Invion Limited (7C8) Actinogen Medical Ltd (ACW) Adherium Ltd (ADR) Argenica Therapeutics Ltd (AGN) Austco Healthcare Ltd (AHC)

Frequently asked questions

What is RHYTHM Biosciences Ltd's market cap?

RHYTHM Biosciences Ltd's market capitalization is AUD 31.14M.